|Institutional Source||Beutler Lab|
|Gene Name||vascular cell adhesion molecule 1|
|Is this an essential gene?||Possibly non essential (E-score: 0.449)|
|Stock #||R0468 (G1)|
|Chromosomal Location||116109949-116129688 bp(-) (GRCm38)|
|Type of Mutation||nonsense|
|DNA Base Change (assembly)||A to T at 116115946 bp|
|Amino Acid Change||Tyrosine to Stop codon at position 577 (Y577*)|
|Ref Sequence||ENSEMBL: ENSMUSP00000029574 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000029574]|
|Predicted Effect||probably null
AA Change: Y577*
AA Change: Y577*
|Predicted Effect||noncoding transcript
|Meta Mutation Damage Score||0.9754|
|Coding Region Coverage||
|Validation Efficiency||100% (61/61)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene is a member of the Ig superfamily and encodes a cell surface sialoglycoprotein expressed by cytokine-activated endothelium. This type I membrane protein mediates leukocyte-endothelial cell adhesion and signal transduction, and may play a role in the development of artherosclerosis and rheumatoid arthritis. Three alternatively spliced transcripts encoding different isoforms have been described for this gene. [provided by RefSeq, Dec 2010]
PHENOTYPE: Most homozygous null mutants die by embryonic day 12.5 due to defective placenta and failure of chorion/allantois fusion, and heart developmental anomalies. Survivors are generally normal, but have high numbers of circulating blood mononuclear leukocytes. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Vcam1||
(F):5'- GGGCAAGCGATTTGGTCTGAAATG -3'
(R):5'- AAGGAAACCACCATCTGGGTCAGC -3'
(F):5'- gcccaaggaagcaaggag -3'
(R):5'- ATCTGGGTCAGCCCCTC -3'